NASDAQ:AVTX

Avalo Therapeutics Stock News

etoro logo Buy AVTX
*Your capital is at risk
$18.91
-0.300 (-1.56%)
At Close: Jul 13, 2026
WAYNE, Pa. and ROCKVILLE, Md., March 08, 2022 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and commerciali
Investors need to pay close attention to Avalo (AVTX) stock based on the movements in the options market lately.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE